Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) EBT Margin (2020 - 2025)

Historic EBT Margin for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to 99.57%.

  • SOPHiA GENETICS's EBT Margin rose 159100.0% to 99.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 98.85%, marking a year-over-year increase of 109100.0%. This contributed to the annual value of 94.01% for FY2024, which is 318400.0% up from last year.
  • Latest data reveals that SOPHiA GENETICS reported EBT Margin of 99.57% as of Q3 2025, which was up 159100.0% from 118.17% recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's EBT Margin registered a high of 82.01% during Q4 2024, and its lowest value of 232.52% during Q1 2022.
  • Its 5-year average for EBT Margin is 140.41%, with a median of 139.18% in 2021.
  • Per our database at Business Quant, SOPHiA GENETICS's EBT Margin surged by 2000000000bps in 2021 and then plummeted by -933400bps in 2022.
  • SOPHiA GENETICS's EBT Margin (Quarter) stood at 200.23% in 2021, then skyrocketed by 47bps to 106.31% in 2022, then plummeted by -33bps to 141.08% in 2023, then soared by 42bps to 82.01% in 2024, then fell by -21bps to 99.57% in 2025.
  • Its EBT Margin was 99.57% in Q3 2025, compared to 118.17% in Q2 2025 and 94.95% in Q1 2025.